mironovak / iStockphoto.com
Pfizer Canada has announced a C$1.2 million (US$931,000) investment for the Neomed Institute in an effort to accelerate transforming scientific discoveries from Canadian universities into innovative therapeutic treatments.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Neomed Institute, Pfizer, Pfizer Canada, therapeutic treatments, scientific discoveries, commercialisation
